Zivo Bioscience Inc (ZIVO) Return on Equity ROE from the third quarter 2025 to third quarter 2024 and annually, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zivo Bioscience Inc   (ZIVO)

Zivo Bioscience Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Zivo Bioscience Inc in the third quarter 2025?
Due to the lack of equity, it was not possible to calculate Zivo Bioscience Inc 's return on equity (ROE) in its third quarter 2025

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -8 -10 -16 -13 -14
Return On Equity (TTM) - - - - -
ZIVO's Total Ranking # # # # #
Equity (TTM) in Millions -3 -3 -2 -1 -2
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to ZIVO Management Effectiveness >> ZIVO's 5 Years Annual ROE >> Compare ZIVO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





ZIVO Annual Return On Equity (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Equity in Millions -1 -2 0 6 -11
Y / Y Equity Change - - - - -
Net Income in Millions -13 -8 -9 -9 -9
Y / Y Net Income Change - - - - -
Return On Equity - - - -151.66 % -

Back to ZIVO Management Effectiveness >> ZIVO's 5 Years Annual ROE >> Compare ZIVO ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ZIVO's' Return on Equity at Yahoo Finance
ZIVO's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ZIVO's Competitors
Subscribers only: Roe for Zivo Bioscience Inc 's Suppliers
Subscribers only: Return On Equity for ZIVO's Customers




Companies with similar Return On Equity at Sep 30 2025, within Healthcare Sector ROE
Abbvie Inc   458.59 %
Silexion Therapeutics Corp  404.14 %
Rigel Pharmaceuticals Inc  204.70 %
Biomx Inc  190.95 %
Halozyme Therapeutics Inc   141.55 %
Tg Therapeutics Inc   133.25 %
Arcutis Biotherapeutics Inc   124.67 %
Stablecoin Development Corporation  113.87 %
Eli Lilly And Company  101.84 %
Champions Oncology Inc   100.89 %
Amgen Inc   96.19 %
Medpace Holdings Inc   91.88 %

Date modified: 2026-09-08T15:11:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.